Product Information
METRONIDAZOLE VAGINAL 0.75% GL is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1479 per GM under NDC 68462018449. Its NADAC has been published 224 times since Mar 16, 2022.
Strength
7.5 mg/g
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462018449
Classification
Generic
Dosage Form
GEL
Route
VAGINAL
Last Updated
6/17/2026
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA215794On Market Since
1/27/2022
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE VAGINAL 0.75% GL has been published 224 times since Mar 16, 2022, and over the history we have for it it has declined 75.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1479 per GM |
|---|---|
| All-time high | $0.6149 (Jun 15, 2022) |
| All-time low | $0.1470 (May 20, 2026) |
| 52-week high | $0.2091 |
| 52-week low | $0.1470 |
| Median price | $0.3014 |
| Average price | $0.3457 |
| Largest weekly change | -40.7% (Nov 20, 2024) |
| Weeks tracked | 224 |
| Tracking since | Mar 16, 2022 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METRONIDAZOLE VAGINAL 0.75% GL?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE VAGINAL 0.75% GL, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1479 per GM (NDC 68462018449), effective Jun 24, 2026.
How has the price of METRONIDAZOLE VAGINAL 0.75% GL changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE VAGINAL 0.75% GL has declined 75.6%. It has been tracked across 224 weekly CMS publications since Mar 16, 2022.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE VAGINAL 0.75% GL?
Since Mar 16, 2022, the NADAC for METRONIDAZOLE VAGINAL 0.75% GL has ranged from a low of $0.1470 (May 20, 2026) to a high of $0.6149 (Jun 15, 2022), with a median of $0.3014 per GM.
Are there cheaper alternatives to METRONIDAZOLE VAGINAL 0.75% GL?
7 NADAC-published products share the same active ingredient, strength, and dosage form as METRONIDAZOLE VAGINAL 0.75% GL, but none are currently priced below it.
Who manufactures METRONIDAZOLE VAGINAL 0.75% GL?
METRONIDAZOLE VAGINAL 0.75% GL (NDC 68462018449) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification